Effect sizes (if > 0.5) for the comparison of increasing load vs. decreasing for the iliocostalis muscle. by Christoph Anders (4068499)

Subjects:

Effect sizes (if > 0.5) for the comparison of increasing load vs. decreasing load for the multifidus muscle. by Christoph Anders (4068499)

Subjects:

Effect sizes (if > 0.5) for the comparison of increasing load vs. decreasing load for the longissimus muscle. by Christoph Anders (4068499)

Subjects:

Effect sizes (if > 0.5) for the comparison of increasing load vs. decreasing load for the rectus abdominis muscle. by Christoph Anders (4068499)

Subjects:

Effect sizes (if > 0.5) for the comparison of increasing load vs. decreasing load for the internal oblique muscle. by Christoph Anders (4068499)

Subjects:

Effect sizes (if > 0.5) for the comparison of increasing load vs. decreasing load for the external oblique muscle. by Christoph Anders (4068499)

Subjects:

Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

“…However, there is concern that by neutralizing the SARS-CoV-2 virus, nMAbs may decrease the availability of antigens to the immune system, potentially impairing the endogenous polyclonal immune response and decreasing long-term immune protection.…”

Results of Multiple Linear Regression. by Benjamin S. Killen (22766029)

Subjects:

The linearly decreasing convergence factor a. by Junhao Wei (6816803)

Engine operating point for the six strategies. by Zhihao Li (359073)

ONSD at T14 and six months after ICU discharge. by Marco Carbonara (11483575)

Subjects:

Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Mode shapes of the first six modes. by Xueting Ma (390540)

The distribution of <i>Giardia duodenalis</i> assemblages in domestic and wild populations of nonhuman mammalian species with a larger number of isolates. by Kareem Hatam-Nahavandi (7384790)

Subjects:

Changes in baseline T-cell exhaustion, monocyte activation and platelet activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Survey-weighted association of flavonoids and six subclasses intake with MASLD. by Yuwei He (1565941)

Subjects:

Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

Middle cerebral artery mean flow velocity at three time points. by Marco Carbonara (11483575)

Subjects:

Households, population and nets surveyed across time points. by Job Oyweri (22041452)

Subjects:

Scatter plot of scores in the first six progress tests by entry cohort. by Franco Romaní-Romaní (21989788)